Press Releases

 
Press Releases
Date Title/Summary View
Mar 9, 2017 LAWRENCE, Mass., March 9, 2017 /PRNewswire/ -- NxStage Medical, Inc. (NASDAQ: NXTM), a leading medical technology company focused on advancing renal care, today announced a series of new research results that highlight the potential for on-site hemodialysis with the NxStage® System One™ in skilled nursing facilities to significantly redu...
Mar 2, 2017 LAWRENCE, Mass., March 2, 2017 /PRNewswire/ -- NxStage Medical, Inc. (NASDAQ: NXTM), a leading medical technology company focused on advancing renal care, today announced that its next generation hemodialysis system has received CE Mark approval.  This innovative system consists of new features and capabilities, including a new touchscreen user int...
Feb 28, 2017 LAWRENCE, Mass., Feb. 28, 2017 /PRNewswire/ -- Highlights: Full-Year Revenue Increases to $366 million, up 9% from 2015 Full-Year Home Revenue Increases to $209 million, up over 14% from 2015 Full-Year Operating Income from Products Business More than Doubles to $23 million O...
Feb 16, 2017 LAWRENCE, Mass., Feb. 16, 2017 /PRNewswire/ -- NxStage Medical, Inc. (Nasdaq: NXTM), a leading medical technology company focused on advancing renal care, today announced that Jeffrey H. Burbank, Founder and Chief Executive Officer, plans to participate in the following schedule of investor conferences. Where applicable, a webcast of the event will...
Feb 3, 2017 LAWRENCE, Mass., Feb. 3, 2017 /PRNewswire/ -- NxStage Medical, Inc. (Nasdaq: NXTM), a leading medical technology company focused on advancing renal care, today announced that Allan Collins, M.D., FACP, a recognized worldwide leader in nephrology, has joined NxStage as Chief Medical Officer to help continue to advance NxStage's innovative pipeline a...
Jan 16, 2017 LAWRENCE, Mass., Jan. 16, 2017 /PRNewswire/ -- NxStage Medical, Inc. (Nasdaq: NXTM), a leading medical technology company focused on advancing renal care, today announced plans to release its financial results for the fourth quarter and full year ended December 31, 2016, on Tuesday, February 28, 2017, before the opening of the financial markets. ...
Nov 16, 2016 LAWRENCE, Mass., Nov. 16, 2016 /PRNewswire/ -- NxStage Medical, Inc. (Nasdaq: NXTM), a leading medical technology company focused on advancing renal care, today announced new findings demonstrating positive outcomes related to more frequent hemodialysis with the NxStage® System One™. The data will be presented at the American Society of ...
Nov 3, 2016 LAWRENCE, Mass., Nov. 3, 2016 /PRNewswire/ -- NxStage Medical, Inc. (Nasdaq: NXTM), a leading medical technology company focused on advancing renal care, today reported third quarter financial results above the top end of its guidance.   Total revenue for the third quarter of 2016 increased 6 percent to $92.0 million, above the h...
Nov 1, 2016 LAWRENCE, Mass., Nov. 1, 2016 /PRNewswire/ -- NxStage Medical, Inc. (Nasdaq: NXTM), a leading medical technology company focused on advancing renal care, today announced that Jeffrey H. Burbank, Founder and Chief Executive Officer, plans to participate in the following schedule of investor conferences. Where applicable, a webcast of the event will ...
Oct 25, 2016 LAWRENCE, Mass., Oct. 25, 2016 /PRNewswire/ -- NxStage Medical, Inc. (Nasdaq: NXTM), a leading medical technology company focused on advancing renal care, today announced that six comprehensive clinical reviews describing the benefits of more frequent hemodialysis were published in the American Journal of Kidney Diseases (AJKD). The rese...
Page:
1
... NextLast
= add release to Briefcase